Tuberculosis and COVID-19: An overlapping situation during pandemic


Sarinoglu R. C. , Sili U. , Eryuksel E., Olgun Yıldızeli Ş. , Cimsit C., Yagci A.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, vol.14, no.7, pp.721-725, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 7
  • Publication Date: 2020
  • Doi Number: 10.3855/jidc.13152
  • Title of Journal : JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
  • Page Numbers: pp.721-725
  • Keywords: COVID-19, Mycobacterium tuberculosis, SARS-CoV-2, PCR, HIV

Abstract

Introduction: The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19). First COVID-19 case was detected in March, 10, 2020 in Turkey and as of May, 18, 2020 148,067 cases have been identified and 4096 citizens have died. Tuberculosis (TB) is a worldwide public health concern, incidence of tuberculosis (per 100,000 people) in Turkey was reported at 14, 1 in 2018. During pandemic COVID-19 was the main concern in every clinic and as we discuss here overlapping respiratory diseases may result in delaying of the diagnosis and treatment.